Administration of anti-granulocyte colony-stimulating factor antibodies suppressed the colon carcinogenesis and significantly increased the levels of NK cells and IFNγ-producing CD4+ and CD8+ T cells (50). This evidence concerns the gene CD4 and digestive system neoplasm.